HER2 Gene Mutation Unknown Status Phase 2 Trials for Pyrotinib (DB14993)

IndicationStatusPhase
DBCOND0081068 (HER2 Gene Mutation)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04179656The Basket Study of Pyrotinib Maleate for HER2-Postive Solid TumorTreatment
NCT03412383Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast CancerTreatment